China Medicine Corporation
CHME · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Revenue | $65 | $54 | $42 | $24 |
| % Growth | 20.7% | 27.4% | 75.5% | – |
| Cost of Goods Sold | $46 | $38 | $30 | $15 |
| Gross Profit | $19 | $16 | $12 | $9 |
| % Margin | 29.3% | 29% | 29.4% | 37.4% |
| R&D Expenses | $1 | $1 | $1 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $5 | $4 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $7 | $5 | $4 | $3 |
| Operating Income | $12 | $11 | $8 | $6 |
| % Margin | 18.9% | 20.4% | 20% | 25.8% |
| Other Income/Exp. Net | -$7 | $0 | $0 | -$0 |
| Pre-Tax Income | $5 | $11 | $8 | $6 |
| Tax Expense | $4 | $2 | $2 | $1 |
| Net Income | $2 | $9 | $7 | $5 |
| % Margin | 2.7% | 17% | 16.3% | 20% |
| EPS | 0.11 | 0.6 | 0.56 | 0.65 |
| % Growth | -81.7% | 7.1% | -13.8% | – |
| EPS Diluted | 0.11 | 0.6 | 0.5 | 0.63 |
| Weighted Avg Shares Out | 15 | 15 | 12 | 7 |
| Weighted Avg Shares Out Dil | 15 | 15 | 14 | 8 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $1 | $0 |
| EBITDA | $13 | $11 | $9 | $6 |
| % Margin | 20.5% | 21.2% | 21.8% | 26.5% |